EGFR

EGFR

The epidermal growth factor receptor (EGFR; ErbB1) is a member of the epidermal growth factor RTK (receptor tyrosine kinases) family, along with HER2/neu (ErbB2), ErbB3 (HER3), and ErbB4 (HER4). The extracellular ligand-binding ectodomain, the single chain transmembrane domain, and the intracellular tyrosine kinase domain make up the EGFR, which is located at the cell surface. Epidermal growth factor (EGF), transforming growth factor (TGF-α), amphiregulin, heparin-binding EGF, and betacellulin are just a few of the ligands that bind to and activate the EGFR.
The tyrosine kinase domain is activated by the receptors' formation of homo- or heterodimeric complexes after ligand binding. The Ras-Raf-MAP kinase, PI-3K/Akt, PKC, and Stat/Jak signaling pathways are all activated as a result of the dimerization and autophosphorylation of EGFR. The EGFR is activated to control cellular survival, differentiation, and proliferation. The EGFR has been derided as a proto-oncogene primarily because of its function in encouraging cell proliferation and preventing apoptosis.

EGFR related products

Structure Cat No. Product Name CAS No. Product Description
V51518 (E/Z)-AG490 134036-52-5 (E/Z)-AG490 ((E/Z)-Tyrphostin AG490) is the racemate of (E)-AG490 and (Z)-AG490.
V51446 EGFR-IN-76 2607829-38-7 EGFR-IN-76 (compound 37A) is a potent reagent for EGFR.
V83212 JBJ-03-142-02 2068806-31-3 JBJ-03-142-02 is an inhibitor of EGFR-HER2 Ex20Ins.
V29472 Lidocaine hydrochloride 73-78-9 Lidocaine hydrochloride monohydrate (also known as Alphacaine; Lignocaine) is a potent and selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 μM.
V50946 Limertinib (ASK-120067) 1934259-00-3 Limertinib (ASK120067) is a potent epidermally active EGFRT790M (IC50= 0.3 nM) and selective for EGFRWT (IC50= 6.0 nM).
V51017 LS-106 EGFR C797S inhibitor
V51197 Mefatinib 1417695-74-9 pan- EGFR inhibitor
Contact Us Back to top